Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 25 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 49.65 and Closed at: 49.24, which is -0.83% of previous session's close. It moved within a range of 49.00 and 50.03
The session was a Bearish session with an average volume of 2390471, which is -18.76% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Golden cross was found 2 days back on short term averages
Support for tomorrow is 48.61 and resistance for tomorrow is 49.64
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 48.82, 48.39 resistance for tomorrow's hourly charts is 49.85, 50.45
10 Day SMA for Glaxosmithkline Plc (GSK) is 50.2 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 49.92 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 50.87 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 51.16 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 52.49 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 49.92 and 200 DMA is at 52.49, while 50 DMA and 100 DMA are at 50.87 and 51.16 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 49.92 and 20 EMA is at 50.14
| Date | Closing Price | 20 SMA | 20 EMA |
| 25 Fri Sep | 49.24 | 49.92 | 50.14 |
| 24 Thu Sep | 49.65 | 49.97 | 50.23 |
| 23 Wed Sep | 49.71 | 50.06 | 50.29 |
| 22 Tue Sep | 50.72 | 50.18 | 50.35 |
| 21 Mon Sep | 51.08 | 50.23 | 50.31 |
| 18 Fri Sep | 50.22 | 50.3 | 50.23 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 50.87 and 50 EMA is at 50.71
| Date | Closing Price | 50 SMA | 50 EMA |
| 25 Fri Sep | 49.24 | 50.87 | 50.71 |
| 24 Thu Sep | 49.65 | 50.92 | 50.77 |
| 23 Wed Sep | 49.71 | 50.98 | 50.82 |
| 22 Tue Sep | 50.72 | 51.01 | 50.87 |
| 21 Mon Sep | 51.08 | 51.02 | 50.88 |
| 18 Fri Sep | 50.22 | 51.05 | 50.87 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 51.16 and 100 EMA is at 51.24
| Date | Closing Price | 100 SMA | 100 EMA |
| 25 Fri Sep | 49.24 | 51.16 | 51.24 |
| 24 Thu Sep | 49.65 | 51.17 | 51.28 |
| 23 Wed Sep | 49.71 | 51.18 | 51.31 |
| 22 Tue Sep | 50.72 | 51.19 | 51.34 |
| 21 Mon Sep | 51.08 | 51.2 | 51.35 |
| 18 Fri Sep | 50.22 | 51.21 | 51.36 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 52.49 and 200 EMA is at 50.41
| Date | Closing Price | 200 SMA | 200 EMA |
| 25 Fri Sep | 49.24 | 52.49 | 50.41 |
| 24 Thu Sep | 49.65 | 52.49 | 50.42 |
| 23 Wed Sep | 49.71 | 52.47 | 50.43 |
| 22 Tue Sep | 50.72 | 52.47 | 50.44 |
| 21 Mon Sep | 51.08 | 52.46 | 50.44 |
| 18 Fri Sep | 50.22 | 52.44 | 50.43 |
Abbvie Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Abbvie Inc, about 6.58% more returns!
Glaxosmithkline Plc has performed better than Abbott Laboratories in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Bristol Myers in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Chemed Corp has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Chemed Corp, about 0.97% more returns!
Davita Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Davita Inc, about 1.89% more returns!
Glaxosmithkline Plc has performed better than Edwards Lifesciences in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Haemonetics Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 4.4% more returns!
Humana Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Humana Inc, about 6.32% more returns!
Eli Lilly has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Eli Lilly, about 3.94% more returns!
3m Company has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in 3m Company, about 0.36% more returns!
Glaxosmithkline Plc has performed better than Nu Skin in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Penumbra Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Penumbra Inc, about 2.24% more returns!
Pfizer Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Pfizer Inc, about 5.72% more returns!
Qiagen N has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Qiagen N, about 5.59% more returns!
Glaxosmithkline Plc has performed better than Resmed Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Steris Plc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Takeda Pharmaceutical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 7.71% more returns!
Glaxosmithkline Plc has performed better than Teladoc Health in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc has performed better than Zimmer Biomet in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Glaxosmithkline Plc in short term but the buy signal is initial and weak.
Glaxosmithkline Plc Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Glaxosmithkline Plc is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.25 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
